- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 241/06 - Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having one or two double bonds between ring members or between ring members and non-ring members
Patent holdings for IPC class C07D 241/06
Total number of patents in this class: 41
10-year publication summary
|
0
|
3
|
2
|
4
|
2
|
1
|
4
|
1
|
1
|
1
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Pliant Therapeutics, Inc. | 65 |
4 |
| Boehringer Ingelheim International GmbH | 4494 |
2 |
| MannKind Corporation | 529 |
2 |
| Medshine Discovery Inc. | 591 |
2 |
| Southern Research Institute | 205 |
2 |
| University of Kansas | 916 |
2 |
| University of Louisville Research Foundation, Inc. | 729 |
2 |
| Duke Street Bio Limited | 17 |
2 |
| 3m Innovative Properties Company | 17491 |
1 |
| Abbott Laboratories | 2272 |
1 |
| Amgen Inc. | 4383 |
1 |
| Glaxosmithkline Intellectual Property Development Limited | 774 |
1 |
| The Trustees of Columbia University in the City of New York | 3627 |
1 |
| Vertex Pharmaceuticals Incorporated | 1589 |
1 |
| Adeka Corporation | 1372 |
1 |
| Ariel-the University Company for Research and Development, Ltd. | 1 |
1 |
| Daiichi Sankyo Company, Limited | 1890 |
1 |
| Hanmi Holdings Co., Ltd | 20 |
1 |
| INVISTA Technologies S.a.r.l. | 399 |
1 |
| Laboratorios Salvat, S.A. | 108 |
1 |
| Other owners | 11 |